GREN yields 20000000.00% · JNJ yields 2.14%● Live data
📍 GREN pulled ahead of the other in Year 1
Combined, GREN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GREN + JNJ for your $10,000?
In June 2003, AgroCan Corporation changed its name to Greensmart Corporation in connection with an asset acquisition agreement with Winsmart Development, Ltd. According to the basic terms of the agreement, the company would issue to Winsmart 29,868,737 shares of its common stock. Also, Winsmart would sell to the company approximately 553,212 young eucalyptus trees planted in a total of 340 leased hectares; and a tree seedling and nursery farm situated on 3.3 leased hectares. Greensmart Corporation, through its subsidiary, AgroCan (China), Inc., specializes in producing compound fertilizers, which are custom-made to suit local conditions, such as plant, soil, and climate. Compound fertilizers are the end product made from the combination of the three primary nutrients: nitrogen, phosphate, and potassium, together with other elements, such as iron, zinc, copper, and manganese. These elements are blended in different proportions, and are made into pellets and packed into bags. Fertilizer applications include mainly paddy rice, wheat, corn, sugar cane, tobacco, cotton, vegetables, tree plantation, and fruit trees. The company's fertilizers are sold under the brand name 'AgroCan Three Leaves'. Its main customers for the fertilizers comprise the farming supply bureaus and cooperatives under the State Internal Trade Bureau of the People's Republic of China. These entities act as wholesalers to individual farmers. State-owned farms and plantations are also major accounts of the company. Greensmart Corporation was founded in 1996 and is based in Kwun Tong, Hong Kong.
Full GREN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.